Research Article

[Retracted] Coronary Angiography Safety between Transradial and Transfemoral Access

Table 2

Procedural and postprocedural outcome of patients ().

VariablesTransradial CAG (; %)Transfemoral CAG (; %) value

Catheters used
 (a) Single catheter1034 (96.1)10 (1.1)0.24
 (b) Catheter (AL/AR/ JR/JL)42 (4.9.)911 (98.9)
Crossover rate
 (a) Radial to femoral31 (2.9)0.001
 (b) Femoral to radial3 (0.3)
UFH1076 (100%)921 (100)0.22
Duration of radial artery compression (Hr.)2.1 ± 0.20.12
Fluoroscopy time (min)2.46 ± 1.222.83 ± 1.310.32
Radiation dose (Gy × cm2)24.2 ± 4.2122.3 ± 3.460.43
Procedure duration8.89 ± 2.729.33 ± 2.820.56
Contrast volume (mL)67.52 ± 22.5471.63 ± 25.410.32
Serum creatinine (mg/dL), post-CAG1.3 ± 0.2 (6 ± 4.5)1.4 ± 0.15 (8 ± 2.6)0.41
RAO56 (5.2)
Vasospasm28 (2.6)
Local site complication43 (3.9)70 (7.6)0.04
Local site pain21 (1.9)38 (4.1)0.04
Haematoma9 (0.83)13 (1.4)0.001
Local site paraesthesia13 (1.2)19 (2.1)0.03

Including one for crossover; UFH: unfractionated heparin; CAG: Coronary Arteriography; RAO: radial artery occlusion.